Amgen (AMGN) Research & Development (2016 - 2025)
Historic Research & Development for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $2.1 billion.
- Amgen's Research & Development rose 2424.59% to $2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.3 billion, marking a year-over-year increase of 2193.16%. This contributed to the annual value of $7.3 billion for FY2025, which is 2193.16% up from last year.
- According to the latest figures from Q4 2025, Amgen's Research & Development is $2.1 billion, which was up 2424.59% from $1.9 billion recorded in Q3 2025.
- In the past 5 years, Amgen's Research & Development ranged from a high of $2.1 billion in Q4 2025 and a low of $959.0 million during Q1 2022
- Over the past 5 years, Amgen's median Research & Development value was $1.3 billion (recorded in 2021), while the average stood at $1.4 billion.
- As far as peak fluctuations go, Amgen's Research & Development plummeted by 2180.03% in 2022, and later surged by 3438.37% in 2024.
- Over the past 5 years, Amgen's Research & Development (Quarter) stood at $1.3 billion in 2021, then fell by 1.78% to $1.3 billion in 2022, then grew by 15.86% to $1.5 billion in 2023, then increased by 12.39% to $1.7 billion in 2024, then rose by 24.25% to $2.1 billion in 2025.
- Its Research & Development was $2.1 billion in Q4 2025, compared to $1.9 billion in Q3 2025 and $1.7 billion in Q2 2025.